ArticleMolecular cancer therapeutics2015

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

Yeon-Jin Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.